Identity
HGNC
LOCATION
3q27.1
LOCUSID
ALIAS
CDG1D,CDGS4,CDGS6,D16Ertd36e,NOT56L,Not56,not
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 10195
MIM: 608750
HGNC: 23056
Ensembl: ENSG00000214160
Variants:
dbSNP: 10195
ClinVar: 10195
TCGA: ENSG00000214160
COSMIC: ALG3
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38329424 | 2024 | Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer. | 0 |
| 38329424 | 2024 | Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer. | 0 |
| 35181625 | 2022 | ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer. | 0 |
| 35676564 | 2022 | Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy. | 13 |
| 35980117 | 2022 | CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis. | 1 |
| 36231102 | 2022 | ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8. | 4 |
| 35181625 | 2022 | ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer. | 0 |
| 35676564 | 2022 | Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy. | 13 |
| 35980117 | 2022 | CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis. | 1 |
| 36231102 | 2022 | ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8. | 4 |
| 33084111 | 2021 | ALG3 contributes to the malignant properties of OSCC cells by regulating CDK-Cyclin pathway. | 7 |
| 33931075 | 2021 | ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer. | 33 |
| 33084111 | 2021 | ALG3 contributes to the malignant properties of OSCC cells by regulating CDK-Cyclin pathway. | 7 |
| 33931075 | 2021 | ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer. | 33 |
| 31899049 | 2020 | ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p. | 22 |
Citation
Dessen P
ALG3 (ALG3 alpha-1,3- mannosyltransferase)
Atlas Genet Cytogenet Oncol Haematol. 2018-11-01
Online version: http://atlasgeneticsoncology.org/gene/57758/alg3-(alg3-alpha-1-3-mannosyltransferase)
